| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $65.4M | +43.7% |
| Cost of Revenue | $17.3M | +32.8% |
| Gross Profit | $48.1M | +48.1% |
| R&D Expense | $20.8M | -5.3% |
| SG&A Expense | $54.5M | +6.2% |
| Operating Income | -$27.2M | +33.4% |
| Interest Expense | $8.5M | +13.1% |
| Net Income | -$33.0M | +30.0% |
| EPS (Basic) | -$1.27 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.1M | +173.4% |
| Short-term Investments | $48.4M | -31.6% |
| Accounts Receivable | $12.3M | +64.6% |
| Inventory | $11.2M | +15.5% |
| Current Assets | $92.7M | -5.1% |
| Total Assets | $107.7M | -5.7% |
| Current Liabilities | $16.2M | +47.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.7M | +46.6% |
| Capital Expenditures | $173K | -71.3% |
| Investing Cash Flow | $23.0M | -3.2% |
| Financing Cash Flow | $8.1M | +1558.6% |
| Free Cash Flow | -$19.9M | +47.0% |
| +33.5% |
| EPS (Diluted) | -$1.27 | +33.5% |
| Long-term Debt |
| $57.0M |
| +7.6% |
| Total Liabilities | $87.0M | +9.7% |
| Stockholders' Equity | $20.7M | -40.6% |